Skip to main content
. 2021 Oct 21;13(21):5287. doi: 10.3390/cancers13215287

Table 3.

CRS history of APVO436-treated R/R AML patients with favorable responses.

Patient ID Cohort CRS Best Overall Response
214-0002 1 +(Grade 3) SD
214-0008 5 - SD
215-0004 6A +(Grade 1) SD
212-0005 6A +(Grade 1) PR
CR
213-0009 6B - PR
CR
214-0011 7 +(Grade 2) SD + PBBC-C+
>50%BMB reduction
213-0012 10 - SD
218-0004 10 - SD/RES

PBBC-C: Clearance of peripheral blood blast count; BMB: bone marrow blast count; SD: stable disease; RES: resistant disease; PR: partial remission; CR: complete remission.